Sanofi-Synthelabo reported 193 BW of sales in 2005.

Published: 2006-03-06 06:55:00

Updated: 2006-03-06 06:55:00

Sanofi-Synthelabo reported the 2005 business performance for 193 billion won of sales, 19.14% up from the previous year, 36,244 million won of operating income (30.95% up), 28,790 million won of ordinary income, 5 billion won more than the previous year, and 19,151 million won of net income.

T...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK